CLBT Cellebrite DI Ltd

  1. Stocks
  2. Technology
  3. NASDAQ: CLBT

Price (delayed)

$15.015

Market cap

$3.7B

P/E Ratio

53.63

Dividend/share

N/A

EPS

$0.28

Enterprise value

$3.59B

?
Relative Growth: Rel. Growth: 74
Relative Strength: Rel. Strength: 48
Relative Valuation: Rel. Valuation: 38
Relative Profitability: Rel. Profitability: 95
Highlights
The equity is up by 40% year-on-year and by 5% since the previous quarter
The gross profit has increased by 18% YoY and by 4% QoQ
The net income has surged by 137% year-on-year but it has declined by 8% since the previous quarter
Cellebrite DI's EPS has surged by 131% YoY but it has decreased by 13% QoQ
The debt has soared by 115% YoY
The quick ratio has contracted by 16% YoY and by 2.7% from the previous quarter
Sector: Technology
Industry: Software - Infrastructure
Website: https://www.cellebrite.com
Peers: PHR PHUN

Key stats

What are the main financial stats of CLBT

CLBT stock price

How has the Cellebrite DI stock price performed over time
Intraday
1.8%
1 week
2.56%
1 month
-4.06%
1 year
9.6%
YTD
-16.72%
QTD
2.84%

Financial performance

How have Cellebrite DI's revenue and profit performed over time
Revenue
$496.43M
Gross profit
$416.33M
Operating income
$63.33M
Net income
$71.86M
Gross margin
83.9%
Net margin
14.5%
The net income has surged by 137% year-on-year but it has declined by 8% since the previous quarter
The net margin has soared by 131% YoY but it has contracted by 12% from the previous quarter
The gross profit has increased by 18% YoY and by 4% QoQ
CLBT's revenue is up by 18% YoY and by 4.4% QoQ

Price vs fundamentals

How does CLBT's price correlate with its fundamentals

Growth

What is Cellebrite DI's growth rate over time

Valuation

What is Cellebrite DI stock price valuation
P/E
53.63
P/B
7.34
P/S
7.45
EV/EBIT
56.68
EV/EBITDA
45.11
EV/Sales
7.23
Cellebrite DI's EPS has surged by 131% YoY but it has decreased by 13% QoQ
The equity is up by 40% year-on-year and by 5% since the previous quarter
The stock's price to book (P/B) is 18% less than its last 4 quarters average of 8.8
CLBT's revenue is up by 18% YoY and by 4.4% QoQ
The P/S is 16% below the last 4 quarters average of 8.7 but 14% above the 5-year quarterly average of 6.4

Efficiency

How efficient is Cellebrite DI business performance
CLBT's return on assets has surged by 127% year-on-year but it is down by 15% since the previous quarter
CLBT's ROE has soared by 119% YoY but it is down by 16% from the previous quarter
Cellebrite DI's return on sales has decreased by 10% YoY and by 9% QoQ
CLBT's return on invested capital is down by 10% year-on-year

Dividends

What is CLBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLBT.

Financial health

How did Cellebrite DI financials performed over time
The total assets is 116% more than the total liabilities
The total assets has grown by 34% YoY
Cellebrite DI's total liabilities has increased by 28% YoY but it has decreased by 2.8% from the previous quarter
The debt is 96% less than the equity
The debt has soared by 115% YoY
The equity is up by 40% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.